market access

News

Roche's blockbuster breast cancer drug Herceptin

Mylan and Biocon launch Herceptin biosimilar in US

Mylan and Biocon have launched their Herceptin biosimilar Ogivri in the US, the second challenger to Roche’s breast and stomach cancer blockbuster.

News

ICER says 'marginal' benefits for AbbVie's new RA drug

AbbVie’s Rinvoq rheumatoid arthritis drug is an important part of the company’s strategy to replace lost sales as its mega-blockbuster Humira finally succumbs to cheaper biosimilar competit

News

Drugs firms make massive discounts to get reimbursement in C...

Roche and Novartis are among the pharmaceuticals companies who have agreed to cut prices of some of their newest drugs by 61% on average to get them reimbursed in China, according to a repo

News

Pills spilling out of a prescription bottle on 100 dollar paper currency

Trump's reps 'pushed hard' for UK drug price reforms, leaked...

Representatives of the Trump administration have “pushed hard” for pro-US drug pricing reforms in free trade negotiations with the UK government, according to leaked documents posted online

News

UK should pay $25 million for 'Netflix' antibiotic subscript...

An expert has said the UK must pay upwards of $25 million per year to drug companies developing new antibiotics under its soon-to-be announced "Netflix" subscription model, which aims to gi

News

Labour peer says he opposes Corbyn-style state-funded drugs ...

A Labour peer has spoken out against the idea of a nationalised drugs industry, saying that proposals for a state-funded drugs company such as that favoured by Jeremy Corbyn would “not be t

Mylan and Biocon launch Herceptin biosimilar in US

ICER says 'marginal' benefits for AbbVie's new RA drug

Drugs firms make massive discounts to get reimbursement in C...

Trump's reps 'pushed hard' for UK drug price reforms, leaked...

UK should pay $25 million for 'Netflix' antibiotic subscript...

Labour peer says he opposes Corbyn-style state-funded drugs ...

As patents expire, fampridine is cleared for NHS use in MS

Discover a new era of healthcare panel engagement: Grounded ...

market access

Editor's Picks